吸入麻醉市場:各產品，各用途，各終端用戶，各地區- 規模，佔有率，展望，機會分析，2023年～2030年

Inhalation Anesthesia Market, By Product, By Application, By End Users, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年05月25日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場動態:

慢性病患病率的增加、老年人口的增加、急診病例和手術數量的增加、吸入麻醉需求的增加以及COVID-19（大流行）的爆發將對預測期內的全球吸入麻醉市場做出貢獻。這是預計增加市場增長的主要因素。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球吸入麻醉市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發佈或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球吸入麻醉市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發佈、類型升級、市場擴張和營銷策略做出明智的決策。
全球吸入麻醉市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球吸入麻醉市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

Inhalation anesthetics (such as nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane; most commonly used agents in practice today) are used for induction and maintenance of general anesthesia in the operating room. Inhaled anesthetics are preferred for maintenance of anesthesia because they allow a more precise control of the anesthetic state and do so at low cost.

Market Dynamics:

Increasing prevalence of chronic disease, growing geriatric (aging) population, increasing number of emergency cases and surgical interventions, increase in demand for inhalation anesthesia, and outbreak of COVID-19 (pandemic) are major factors expected to augment the growth of the global inhalation anesthesia market during the forecast period.

For instance, in August 2022, Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announced the First to Market Generic U.S. launch of the Zinc Sulfate Injection. This product is U.S. Food and Drug Administration approved with Competitive Generic Therapy (CGT) designation; an approval pathway intended to enhance market competition for sole source drugs. The injection is available in 30mg/10mL (3mg/mL) and 25mg/5mL (5mg/mL).

Key features of the study:

This report provides in-depth analysis of the global inhalation anesthesia market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2020 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global inhalation anesthesia market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbvie Inc., Novartis AG, Piramal Enterprises Ltd., Hikma Pharmaceuticals Plc, Fresenius SE & CO. KGaA, Halocarbon Products Corporation, Baxter International Inc., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global inhalation anesthesia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation anesthesia market.

Detailed Segmentation:

Global Inhalation Anesthesia Market, By Product:
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
Global Inhalation Anesthesia Market, By Application:
- Induction
- Maintenance
Global Inhalation Anesthesia Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
Global Inhalation Anesthesia Market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Abbvie Inc.
- Novartis AG
- Piramal Enterprises Ltd.
- Hikma Pharmaceuticals Plc
- Fresenius SE & CO. KgaA
- Baxter International Inc.
- Troikaa Pharmaceuticals, Ltd.
- Halocarbon Products Corporation
- Jiangsu Hengrui Medicine Co., Ltd.
- Lunan Pharmaceutical Group Co. Ltd.

Market Dynamics
- High burden of chronic disease and growing geriatric population
- Side-effects and rise in demand or adoption of generic drugs
- Increasing demand or use of novel inhalation anesthetic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Inhalation Anesthesia Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Inhalation Anesthesia Market, By Product, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Sevoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Nitrous Oxide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Inhalation Anesthesia Market, By Application, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Inhalation Anesthesia Market, By End User, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

8. Global Inhalation Anesthesia Market, By Geography, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

9. Competitive Landscape

Abbvie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Piramal Enterprises Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius SE & CO. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Troikaa Pharmaceuticals, Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Halocarbon Products Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jiangsu Hengrui Medicine Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lunan Pharmaceutical Group Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views